Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Mankind Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543904NSE Symbol: MANKINDP/E(TTM):55.18
ISIN Demat:INE634S01028Div & Yield %:0EPS(TTM):40.36
Book Value(Rs):375.7344945Market Cap ( Cr.):91927.56Face Value(Rs):1
    Change Company 
Date Headline
09-Jan-26 Mankind Pharma to discuss results
23-Dec-25 Mankind Pharma Ltd spurts 1.94%, up for fifth straight session
26-Nov-25 Mankind Pharma allots 46,582 equity shares under ESOP
13-Nov-25 Volumes soar at SBI Cards & Payment Services Ltd counter
11-Nov-25 Mankind Pharma Ltd eases for fifth straight session
07-Nov-25 Mankind Pharma Ltd - Mankind Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
07-Nov-25 Mankind Pharma Ltd - Mankind Pharma Limited - Copy of Newspaper Publication
06-Nov-25 Mankind Pharma consolidated net profit declines 21.72% in the September 2025 quarter
06-Nov-25 Mankind Pharma Ltd - Mankind Pharma Limited - Investor Presentation
06-Nov-25 Mankind Pharma Ltd - Mankind Pharma Limited - Outcome of Board Meeting
<< < 1 2 3 4   > >>